Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoya Hamaguchi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Diabetes Research and Clinical Practice|November 27, 2004
Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamideTomoya Hamaguchi, Takahisa Hirose, Hideki Asakawa, et al.
World Journal of Diabetes|October 16, 2014
Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitusHiroyuki Konya, Masayuki Miuchi, Kahori Satani, et al.
Endocrine Journal|January 24, 2014
Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetesMasaru Tokuda, Tomoyuki Katsuno, Fumihiro Ochi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Incretin responses to oral glucose load in Japanese non-obese healthy subjectsEtsuko Nagai, Tomoyuki Katsuno, Jun-Ichiro Miyagawa, et al.
Endocrine Journal|August 27, 2011
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitusEtsuko Nagai, Tomoyuki Katsuno, Jun-Ichiro Miyagawa, et al.
Therapeutics and Clinical Risk Management|July 23, 2014
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patientsHiroyuki Konya, Yuzo Yano, Satoshi Matsutani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2013
Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitusYoshiki Kusunoki, Tomoyuki Katsuno, Kana Miyakoshi, et al.
Metabolism: Clinical and Experimental|January 15, 2010
Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitusHiroyuki Konya, Yoshikazu Hasegawa, Tomoya Hamaguchi, et al.
Clinical Nutrition ESPEN|January 14, 2024
Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetesTsukasa Kuriyama, Chisaki Ishibashi, Junji Kozawa, et al.
Endocrine Journal|December 11, 2012
Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptinYoshiki Kusunoki, Tomoyuki Katsuno, Makiko Myojin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diabetes Research and Clinical Practice|November 27, 2004
Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamideTomoya Hamaguchi, Takahisa Hirose, Hideki Asakawa, et al.
World Journal of Diabetes|October 16, 2014
Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitusHiroyuki Konya, Masayuki Miuchi, Kahori Satani, et al.
Endocrine Journal|January 24, 2014
Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetesMasaru Tokuda, Tomoyuki Katsuno, Fumihiro Ochi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Incretin responses to oral glucose load in Japanese non-obese healthy subjectsEtsuko Nagai, Tomoyuki Katsuno, Jun-Ichiro Miyagawa, et al.
Endocrine Journal|August 27, 2011
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitusEtsuko Nagai, Tomoyuki Katsuno, Jun-Ichiro Miyagawa, et al.
Therapeutics and Clinical Risk Management|July 23, 2014
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patientsHiroyuki Konya, Yuzo Yano, Satoshi Matsutani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2013
Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitusYoshiki Kusunoki, Tomoyuki Katsuno, Kana Miyakoshi, et al.
Metabolism: Clinical and Experimental|January 15, 2010
Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitusHiroyuki Konya, Yoshikazu Hasegawa, Tomoya Hamaguchi, et al.
Clinical Nutrition ESPEN|January 14, 2024
Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetesTsukasa Kuriyama, Chisaki Ishibashi, Junji Kozawa, et al.
Endocrine Journal|December 11, 2012
Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptinYoshiki Kusunoki, Tomoyuki Katsuno, Makiko Myojin, et al.
Pageof 3